In mice receiving chronic intermittent hypoxia as a model of sleep apnea syndrome (SAS), cardiac ACE2 mRNA was overexpressed and was further augmented by telmisartan [72]. This evidence concerns the gene ACE2 and SATB2 associated disorder.